Bernard Denoyer

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.

Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY.

META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT.

Part of Alanco Technologies, Inc., Environetics, Inc. is committed to improving water quality through the development of products which help to solve industrial and municipal water and wastewater quality problems. The company is based in Scottsdale, AZ. The company produces tank & clearwell baffles and covers that provide practical solutions for improving water, wastewater, and air quality. Environetics improves waste treatment by offering a quick, efficient, and satisfactory way to upgrade tank based waste treatment operations through the installation of a Director II system. Environetics was acquired by Alanco Technologies, Inc. on January 06, 1995.